TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32493215

Group type: EXPERIMENTAL
Intervention: Prasugrel or ticagrelor for carriers of CYP2C19*2 loss‐of‐function allele
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Clopidogrel for non-carriers of CYP2C19*2 loss‐of‐function allele
Number of subjects: 1500
Study: 35780106

Group type: EXPERIMENTAL
Intervention: SAYGo airway topical anesthesia and superior laryngeal nerve (SLN) block combined with transtracheal injection (TTI)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard anesthetic regimen (Group C)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: SAYGo airway topical anesthesia and SLN block combined with TTI
Number of subjects: 66
Study: 33939193

Group type: EXPERIMENTAL
Intervention: Systemic amoxicillin (AMX) plus metronidazole (MTZ)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Full-mouth mechanical debridement and decontamination with chlorhexidine
Number of subjects: 62
Study: 34103619

Group type: EXPERIMENTAL
Intervention: CT-enhanced radiomics model
Number of subjects: 292

Group type: COMPARATOR
Intervention: Clinical prediction model
Number of subjects: 292
Study: 34515623

Group type: EXPERIMENTAL
Intervention: Non-problematic video game use
Number of subjects: 3939

Group type: EXPERIMENTAL
Intervention: Problematic video game use
Number of subjects: 3939
Study: 33381805

Group type: EXPERIMENTAL
Intervention: Rapid rewarming (at >0.5°C/h)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Slow rewarming (at ≤0.5°C/h)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rapid rewarming
Number of subjects: 100

Group type: COMPARATOR
Intervention: Slow rewarming
Number of subjects: 100
Study: 35148020

Group type: EXPERIMENTAL
Intervention: PSA stimulation
Number of subjects: 45

Group type: COMPARATOR
Intervention: VIM stimulation
Number of subjects: 45
Study: 34322547

Group type: EXPERIMENTAL
Intervention: Single-inhaler triple therapy (12.5 μg glycopyrronium, 12 μg formoterol, 250 μg fluticasone)
Number of subjects: 396

Group type: COMPARATOR
Intervention: Open-triple therapy (50 μg glycopyrronium co-administered with 12 μg formoterol and 250 μg fluticasone)
Number of subjects: 396
Study: 34357480

Group type: EXPERIMENTAL
Intervention: Oro-buccal administered cannabidiol-dominant anti-inflammatory formulation (MDCNB-02)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 32992570

Group type: EXPERIMENTAL
Intervention: 0.5 Hz saccadic eye movement (SEM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 2 Hz saccadic eye movement (SEM)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 3 Hz saccadic eye movement (SEM)
Number of subjects: 17
Study: 35669747

Group type: EXPERIMENTAL
Intervention: Experimental group (segmented simulation curriculum)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (single case running and debriefing)
Number of subjects: 55
Study: 34501213

Group type: EXPERIMENTAL
Intervention: Core stability physiotherapy
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study: 33036790

Group type: EXPERIMENTAL
Intervention: Clomiphene, letrozole, or gonadotropins with intrauterine insemination for women with UI; Clomiphene or letrozole with regular intercourse for women with PCOS.
Number of subjects: 1650

Group type: COMPARATOR
Intervention: Weight gain of ≥3 kg in women with PCOS.
Number of subjects: 1650
Study: 35266085

Group type: EXPERIMENTAL
Intervention: 15 units of BTX around the eye and normal saline around the mouth (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 15 units of BTX around both the eye and the mouth (group B)
Number of subjects: 60
Study: 33010998

Group type: EXPERIMENTAL
Intervention: Decision aid with cartoon pictures (intervention)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 110
Study: 35759282

Group type: EXPERIMENTAL
Intervention: Transitional Tobacco Care Management (TTCM)
Number of subjects: 1409

Group type: COMPARATOR
Intervention: Community-based quitline (QL)
Number of subjects: 1409
Study: 32798174

Group type: EXPERIMENTAL
Intervention: Lavender oil intervention before ERCP
Number of subjects: 90
Study: 616121449

Group type: EXPERIMENTAL
Intervention: Personalized reminder letters and telephone calls
Number of subjects: 250

Group type: COMPARATOR
Intervention: Usual care (no reminder calls or letters)
Number of subjects: 250
Study: 33320726

Group type: EXPERIMENTAL
Intervention: Mutant 7 (40 Gy‐5)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mutant 10 (40 Gy‐8)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Check variety 'Avadh'
Number of subjects: 90
Study: 33963477

Group type: EXPERIMENTAL
Intervention: InThistoGether (ITG) text messaging-based HIV prevention program
Number of subjects: 202

Group type: COMPARATOR
Intervention: Attention-matched control group promoting general health
Number of subjects: 202
Study: 32542578

Group type: EXPERIMENTAL
Intervention: Mentoring groups
Number of subjects: 676

Group type: COMPARATOR
Intervention: Control condition (pairs not embedded in a group)
Number of subjects: 676
Study: 34543751

Group type: EXPERIMENTAL
Intervention: Prophylactic manual rotation
Number of subjects: 160

Group type: COMPARATOR
Intervention: Sham rotation
Number of subjects: 160
Study: 33515757

Group type: EXPERIMENTAL
Intervention: Continuous Subcutaneous Insulin Infusion (CSII)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple Daily Injections (MDI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prestudy U-500R
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-U-500R
Number of subjects: 0
Study: 33549502

Group type: EXPERIMENTAL
Intervention: Men (postoperative pupillary diameter reduction)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Women (postoperative pupillary diameter reduction)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Men (photopic postoperative pupil reduction)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Women (photopic postoperative pupil reduction)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Correlation of photopic pupillary changes in women with age
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Correlation of mesopic pupillary changes in men with age
Number of subjects: 109
Study: 33591620

Group type: EXPERIMENTAL
Intervention: RDN from the adventitia of the renal artery plus unilateral laparoscopic adrenalectomy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Adrenalectomy alone (control group)
Number of subjects: 60
Study: 33131222

Group type: EXPERIMENTAL
Intervention: Continuous Quality Improvement (CQI) intervention supported by CQI mentors in seven primary care clinics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CQI intervention
Number of subjects: 0
Study: 33798308

Group type: EXPERIMENTAL
Intervention: Ginger-separated moxibustion, 30 min each time, once every other day, three times a week for 4 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Normal diet and moderate exercise
Number of subjects: 62
Study: 616039576

Group type: EXPERIMENTAL
Intervention: Eye gel (FC formulated as eye gel)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Eye drops (FC formulated as eye drops)
Number of subjects: 16
Study: 35405005

Group type: EXPERIMENTAL
Intervention: Universal adhesive applied on dry dentin
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Universal adhesive applied on moist dentin
Number of subjects: 45
Study: 33766150

Group type: EXPERIMENTAL
Intervention: Sertraline plus olanzapine (n = 64)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Sertraline plus placebo (n = 62)
Number of subjects: 269
Study: 32812840

Group type: EXPERIMENTAL
Intervention: Stuttering treatment integrated with evidence-based parenting support (EBPS) for children with eADHD (eADHDintegrated)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Stuttering treatment only for children with eADHD (eADHDstandard)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Stuttering treatment only for children without eADHD (No-eADHDstandard)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Stuttering treatment integrated with EBPS for children with eADHD (eADHDintegrated)
Number of subjects: 76
Study: 35373603

Group type: EXPERIMENTAL
Intervention: Topical Tranexamic Acid (TA)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 74
Study: 33388462

Group type: EXPERIMENTAL
Intervention: Postpartum depression symptoms assessment using the Edinburgh Postnatal Depression Scale (EPDS)
Number of subjects: 3174

Group type: EXPERIMENTAL
Intervention: Higher parity (≥3 previous deliveries)
Number of subjects: 3174

Group type: EXPERIMENTAL
Intervention: Higher maternal and paternal schooling, presence of husband or partner, support from child's father and family during pregnancy
Number of subjects: 3174
Study: 34697250

Group type: EXPERIMENTAL
Intervention: Gait retraining with visual biofeedback
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no feedback on running biomechanics)
Number of subjects: 24
Study: 33370517

Group type: EXPERIMENTAL
Intervention: Nondamaging retinal laser therapy (NRT)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NRT
Number of subjects: 12
Study: 32631324

Group type: EXPERIMENTAL
Intervention: REACH-HF plus usual care
Number of subjects: 216

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 216
Study: 35982464

Group type: EXPERIMENTAL
Intervention: CC-99677
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 32183608

Group type: EXPERIMENTAL
Intervention: Iodine-containing prenatal multiple micronutrient (MMN) supplement (300 μg of iodine)
Number of subjects: 875

Group type: COMPARATOR
Intervention: Iron and folic acid (FeFol) supplement
Number of subjects: 875
Study: 35191982

Group type: EXPERIMENTAL
Intervention: Ticagrelor in preadmission aspirin and/or clopidogrel group
Number of subjects: 4018

Group type: COMPARATOR
Intervention: Prasugrel in preadmission aspirin and/or clopidogrel group
Number of subjects: 4018

Group type: EXPERIMENTAL
Intervention: Ticagrelor in no preadmission aspirin or clopidogrel group
Number of subjects: 4018

Group type: COMPARATOR
Intervention: Prasugrel in no preadmission aspirin or clopidogrel group
Number of subjects: 4018
Study: 33370510

Group type: EXPERIMENTAL
Intervention: 10 mg intravenous ketorolac
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 20 mg intravenous ketorolac
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 30 mg intravenous ketorolac
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Rescue analgesic (0.1 mg/kg intravenous morphine sulfate)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 165
Study: 35228846

Group type: EXPERIMENTAL
Intervention: Low-volume HIIT (n = 16)
Number of subjects: 35

Group type: COMPARATOR
Intervention: MICT (n = 19)
Number of subjects: 35
Study: 36122874

Group type: EXPERIMENTAL
Intervention: Primary intraocular lens (IOL) implantation
Number of subjects: 114

Group type: COMPARATOR
Intervention: No IOL implantation (contact lens [CL])
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Eyes with glaucoma
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Fellow eyes
Number of subjects: 114
Study: 32942346

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5-3 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cariprazine 1.5 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cariprazine overall (1.5-3 mg/d)
Number of subjects: 0
Study: 35306502

Group type: EXPERIMENTAL
Intervention: ACT‐DL+TAU
Number of subjects: 148
Study: 32050833

Group type: EXPERIMENTAL
Intervention: Alveolar Ridge Preservation (ARP) using socket grafting with a particulate bone allograft and socket sealing with a nonabsorbable membrane (dPTFE)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Tooth extraction only (EXT)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Alveolar Ridge Preservation (ARP)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 53
Study: 34244378

Group type: EXPERIMENTAL
Intervention: Paratroopers
Number of subjects: 196336

Group type: COMPARATOR
Intervention: Non-paratroopers
Number of subjects: 196336
Study: 33430891

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (120 mg IV once daily on days 1, 2, and 3) plus standard of care
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (0.9% saline IV once daily on days 1, 2, and 3) plus standard of care
Number of subjects: 72
Study: 34967844

Group type: EXPERIMENTAL
Intervention: GnRHa (3.6 mg goserelin or 3.75 mg leuprorelin injected subcutaneously once every 28 days)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control (chemotherapy without GnRHa)
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: GnRHa group
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: GnRHa group (in patients younger than 35 years)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group (in patients younger than 35 years)
Number of subjects: 330
Study: 33931353

Group type: EXPERIMENTAL
Intervention: Peer comparison (PC) intervention
Number of subjects: 4589

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4589
Study: 32118304

Group type: EXPERIMENTAL
Intervention: Surgically managed (SX) horses
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Non-surgically managed (non-SX) horses
Number of subjects: 98

Group type: COMPARATOR
Intervention: Unexposed horses
Number of subjects: 98
Study: 33588478

Group type: EXPERIMENTAL
Intervention: Xylazine (0.1 mg/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Detomidine (0.03 mg/kg)
Number of subjects: 10
Study: 32480409

Group type: COMPARATOR
Intervention: Goserelin acetate plus 0 grams of testosterone gel (placebo)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Goserelin acetate plus 1.25 grams of testosterone gel
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Goserelin acetate plus 2.5 grams of testosterone gel
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Goserelin acetate plus 5 grams of testosterone gel
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Goserelin acetate plus 10 grams of testosterone gel
Number of subjects: 177
Study: 36300485

Group type: EXPERIMENTAL
Intervention: Positive reading
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Neutral reading
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control
Number of subjects: 120
Study: 34517431

Group type: EXPERIMENTAL
Intervention: Approach: approaching important goals that they have been avoiding
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Reward: increasing pleasant, rewarding behaviors
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control: monitoring only
Number of subjects: 66
Study: 35210331

Group type: EXPERIMENTAL
Intervention: Endovascular therapy (EVT)
Number of subjects: 1764

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 1764
Study: 32690738

Group type: EXPERIMENTAL
Intervention: STARWAVe clinical prediction rule (CPR)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Shorter illness duration (3 days)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Vomiting present
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Wheeze present
Number of subjects: 252
Study: 35524405

Group type: EXPERIMENTAL
Intervention: Eptinezumab (100 mg and 300 mg doses)
Number of subjects: 895

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 895

Group type: EXPERIMENTAL
Intervention: Eptinezumab
Number of subjects: 895
Study: 34779394

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Niraparib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rucaparib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33080951

Group type: EXPERIMENTAL
Intervention: Bullying intervention training for middle managers
Number of subjects: 142
Study: 36100210

Group type: EXPERIMENTAL
Intervention: Kangaroo mother care (KMC) training using the role-play method
Number of subjects: 2

Group type: COMPARATOR
Intervention: Routine methods (control group)
Number of subjects: 2
Study: 33187890

Group type: EXPERIMENTAL
Intervention: Onabotulinum toxin A
Number of subjects: 46

Group type: COMPARATOR
Intervention: Extended-release tolterodine
Number of subjects: 46
Study: 33063932

Group type: EXPERIMENTAL
Intervention: Structured 10-week exercise program (progressive aerobic and resistance exercise)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Structured 10-week exercise program
Number of subjects: 43
Study: 33487155

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg/day (n=73)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Warfarin (n=36)
Number of subjects: 109
Study: 34267085

Group type: EXPERIMENTAL
Intervention: cCBT with Internet support group
Number of subjects: 403

Group type: COMPARATOR
Intervention: cCBT without Internet support group
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 403
Study: 33084584

Group type: EXPERIMENTAL
Intervention: Counseling and mobile health-based physical activity intervention with Fitbit usage
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Baseline daily steps
Number of subjects: 17
Study: 36428089

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) intervention
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Sedentary Behaviour (SB) intervention
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Combined PA and SB groups
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: PA group
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: SB intervention
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Combined group
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Blood parameters
Number of subjects: 564
Study: 36654481

Group type: EXPERIMENTAL
Intervention: Concentrated pomegranate juice (PJ) 45 ml/day
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group without intervention
Number of subjects: 44
Study: 33472675

Group type: EXPERIMENTAL
Intervention: C1 esterase/kallikrein inhibitor 20 U/kg intravenously on day 1 and day 4 plus standard care
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Icatibant 30 mg subcutaneously, three doses/day for 4 days plus standard care
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 180
Study: 36156313

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: High-power diode laser (DL)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (standard chemo-mechanical treatment)
Number of subjects: 39
Study: 33357677

Group type: EXPERIMENTAL
Intervention: Calcium (Ca) at levels of 2.68%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Available phosphorus (aP) at levels of 0.38%
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Calcium (Ca) levels increased linearly
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Calcium (Ca) levels
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Daily feed intake (DFI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bone density (BD) and bone resistance (BR)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bone resistance (BR) of the femur
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Feed conversion ratio per egg dozen
Number of subjects: 30
Study: 32753043

Group type: EXPERIMENTAL
Intervention: Multidirectional stitching technology
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional suture method
Number of subjects: 40
Study: 34808036

Group type: EXPERIMENTAL
Intervention: 3.7 g day-1 n-3 fatty acids (fish oil)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 200 mg fenofibrate
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 32804248

Group type: EXPERIMENTAL
Intervention: Locking plates
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonlocking plates
Number of subjects: 60
Study: 35396307

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN) 4.5 mg once daily for 12 weeks
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 33822748

Group type: EXPERIMENTAL
Intervention: Pornographic videos
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Pornographic cues
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control videos
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control cues
Number of subjects: 74
Study: 32540922

Group type: EXPERIMENTAL
Intervention: Substantial decrease in HbA1c (≥10%)
Number of subjects: 8576

Group type: EXPERIMENTAL
Intervention: Substantial increase in HbA1c (≥10%)
Number of subjects: 8576

Group type: EXPERIMENTAL
Intervention: Greater long-term variability in HbA1c (per 1 SD of ASV)
Number of subjects: 8576
Study: 34120223

Group type: EXPERIMENTAL
Intervention: T-DM1 3.6 mg/kg IV every 3 weeks × 17
Number of subjects: 123

Group type: COMPARATOR
Intervention: Paclitaxel (T) 80 mg/m2 with trastuzumab (H) IV qw × 12 (4 mg/kg load → 2 mg/kg), followed by H (6 mg/kg IV q3w × 13)
Number of subjects: 123
Study: 32538009

Group type: EXPERIMENTAL
Intervention: Filiform fire needling
Number of subjects: 66

Group type: COMPARATOR
Intervention: Oral analgesics (bucinnazine hydrochloride and oxycodone hydrochloride)
Number of subjects: 66
Study: 36315066

Group type: EXPERIMENTAL
Intervention: Internet-delivered pain management program
Number of subjects: 1333

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 1333
Study: 33416043

Group type: EXPERIMENTAL
Intervention: Online psychoeducation and peer support for adult carers
Number of subjects: 407
Study: 32941439

Group type: EXPERIMENTAL
Intervention: Message valence (empathic accurate response) and modality (with emojis)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Synchronicity (immediate response)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Social presence
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Subjective social presence
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Perceived and subjective social presence
Number of subjects: 160
Study: 36502317

Group type: EXPERIMENTAL
Intervention: Remote Expressive Arts Program (rEAP)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 73